Back to Journals » Journal of Hepatocellular Carcinoma » Volume 4

Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

Total article views   Abstract views HTML views PDF downloads Totals
17,510 Dovepress* 10,825 4,060+ 1,099 14,885
PubMed Central* 0 2,625 244 2,625
Totals 10,825 6,685 1,343 17,510
*Since 12 April 2017
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
219 0 0 0 3 216

View citations on PubMed Central and Google Scholar